Home / Health / Five Blood Cancer Patients Beat Relapse with CAR-T
Five Blood Cancer Patients Beat Relapse with CAR-T
3 Jul
Summary
- Apollo Cancer Centres in Visakhapatnam has completed CAR-T therapy.
- The therapy was successful in five patients with relapsed blood cancers.
- A multidisciplinary team ensured patient safety and clinical precision.
In a significant advancement for oncology, Apollo Cancer Centres in Visakhapatnam has successfully administered Chimeric Antigen Receptor T-cell (CAR-T) therapy to five patients. These individuals were battling relapsed and refractory blood cancers, a condition often resistant to conventional treatments.
The groundbreaking treatment was overseen by Senior Medical and Haemato-Oncologist Dr. Rakesh Reddy Boya. He was supported by a dedicated team comprising experts in critical care, transfusion medicine, pharmacy, nursing, and laboratory services. This collaborative approach ensured comprehensive care for each patient.
Every patient underwent a detailed evaluation process. This was followed by a strict preparatory protocol designed to optimize their readiness for the therapy. Crucially, intensive monitoring was conducted post-infusion, reflecting the centre's commitment to the highest standards of patient safety and clinical excellence.
